Author

Carter C. Somerville

Lyell Immunopharma (United States)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioinformatics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

Benjamin D. HarrisiD· 1 shared Betsy Jo BarnesiD· 1 shared Bharati MattaiD· 1 shared Gurinder S. AtwaliD· 1 shared Jason A. CarteriD· 1 shared Jenna BattagliaiD· 1 shared Margaret LaPaniD· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioinformatics

Benjamin D. HarrisORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Identification of pan-cancer/testis genes and validation of therapeutic targeting in triple-negative breast cancer: Lin28a- and Siglece-based vaccination induces anti-tumor immunity and inhibits metastasis

Jason A. Carter, Bharati Matta, Jenna Battaglia, Carter C. Somerville, Benjamin D. Harris, Margaret LaPan, Gurinder S. Atwal, Betsy Jo Barnes

The paper identifies pan-cancer/testis genes and validates their use as therapeutic targets in triple-negative breast cancer through vaccination with Lin28a and Siglece antigens, showing reduced tumor growth and metastasis.

bioRxiv · May 9, 2023 · PreprintBioinformatics